Business
MedMira Grants Stock Options to Directors and Officers
HALIFAX, June 12 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR, NASDAQ: MMIRF), a developer...
About this update from Medmira Inc.
[{"type":"text","content":"\n\n\n\nHALIFAX, June 12 /CNW/ - MedMira Inc., ("MedMira") (TSX Venture: MIR,\nNASDAQ: MMIRF), a developer and marketer of rapid diagnostic technology and\nsolutions, announced today that stock options will be granted to the company's\ndirectors and officers, under the plan that was approved by shareholders at\nits Annual General Meeting in January 2009. A total of 1,800,000 options to\npurchase common shares of the Company will be issued. These options are at an\nexercise price of $0.10 per share and are exercisable for a period of three\nyears. The grant is subject to the approval of the TSX Venture Exchange.\n\n\n"Shaped by the members of our board and executive team, MedMira is\nsteadfast in its strategic business initiatives that are driving the company\nforward," said Dr. James Smith, Chairman, MedMira Inc. "Our officers and\ndirectors are an engaged group of talented and experienced individuals. Their\nexpertise is essential at this time of growth within the Company, and granting\nthese stock options will provide the Company the ability to retain these key\npersonnel in a highly competitive market."\n\n\nAbout MedMira\n\n\nMedMira is a leading developer and manufacturer of flow-through rapid\ndiagnostics. The company's tests provide hospitals, labs, clinics and\nindividuals with reliable, rapid diagnosis for diseases such as HIV and\nhepatitis C in just three minutes. The company's tests are sold under the\nReveal(R), MiraWell(R), MiraCare(TM) and Multiplo(TM) brands in global\nmarkets. MedMira's rapid HIV test is the only one in the world to achieve\nregulatory approvals in Canada, the United States, China and the European\nUnion. MedMira's corporate offices and manufacturing facilities are located in\nHalifax, Nova Scotia, Canada. For more information visit MedMira's website at\nwww.medmira.com.\n\n\nThis news release contains forward-looking statements, which involve risk\nand uncertainties and reflect the company's current expectation regarding\nfuture events. Actual events could materially differ from those projected\nherein and depend on a number of factors including, but not limited to,\nchanging market conditions, successful and timely completion of clinical\nstudies, uncertainties related to the regulatory approval process,\nestablishment of corporate alliances and other risks detail...